Clinical Characteristics of Patients with Newly Diagnosed Diabetic Macular Edema in Turkey: A Real-Life Registry Study—TURK-DEM
Purpose. To evaluate the clinical and diagnostic characteristics of patients with newly diagnosed diabetic macular edema (DME) in Turkey in a real-life setting. Methods. A total of 945 consecutive patients (mean (SD) age: 61.3 (9.9) years, 55.2% male) with newly diagnosed DME were included. Data on...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2017/3596817 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832565493285781504 |
---|---|
author | Bora Eldem Sengul Ozdek Ali Osman Saatci Emin Ozmert Esat Ulay Gulsah Nomak |
author_facet | Bora Eldem Sengul Ozdek Ali Osman Saatci Emin Ozmert Esat Ulay Gulsah Nomak |
author_sort | Bora Eldem |
collection | DOAJ |
description | Purpose. To evaluate the clinical and diagnostic characteristics of patients with newly diagnosed diabetic macular edema (DME) in Turkey in a real-life setting. Methods. A total of 945 consecutive patients (mean (SD) age: 61.3 (9.9) years, 55.2% male) with newly diagnosed DME were included. Data on patient demographics, comorbidities, ocular history, ophthalmic examination findings including type of DME, central macular thickness (CMT) via time domain (TD) and spectral domain (SD) optical coherence tomography (OCT), and planned treatments were recorded. Results. OCT (98.8%) and fundoscopy (92.9%) were the two most common diagnostic methods. Diffuse and focal DMEs were detected in 39.2% and 36.9% of cases, respectively. Laser photocoagulation (32.1%) and antivascular endothelial growth factors (anti-VEGF; 31.8%) were the most commonly planned treatments. The median CMT in the right eye was significantly greater in untreated than in treated patients [376.5 μm (range: 160–840) versus 342 μm (range: 146–999) (p=0.002)] and in the left eye [370 μm (range: 201–780) versus 329 μm (range: 148–999) (p<0.001)]. Conclusions. This study is the first large-scale real-life registry of DME patients in Turkey. SD-OCT and fundoscopy were the most common diagnostic methods. Laser photocoagulation and anti-VEGF therapy were the most common treatments. |
format | Article |
id | doaj-art-1f0714f0ecf14a4dbf8d9b90776abbf0 |
institution | Kabale University |
issn | 2090-004X 2090-0058 |
language | English |
publishDate | 2017-01-01 |
publisher | Wiley |
record_format | Article |
series | Journal of Ophthalmology |
spelling | doaj-art-1f0714f0ecf14a4dbf8d9b90776abbf02025-02-03T01:07:31ZengWileyJournal of Ophthalmology2090-004X2090-00582017-01-01201710.1155/2017/35968173596817Clinical Characteristics of Patients with Newly Diagnosed Diabetic Macular Edema in Turkey: A Real-Life Registry Study—TURK-DEMBora Eldem0Sengul Ozdek1Ali Osman Saatci2Emin Ozmert3Esat Ulay4Gulsah Nomak5Department of Ophthalmology, Hacettepe University Faculty of Medicine, Ankara, TurkeyDepartment of Ophthalmology, Gazi University Faculty of Medicine, Ankara, TurkeyDepartment of Ophthalmology, Dokuz Eylul University Faculty of Medicine, Izmir, TurkeyDepartment of Ophthalmology, Ankara University Faculty of Medicine, Ankara, TurkeyBayer Türk, Istanbul, TurkeyBayer Türk, Istanbul, TurkeyPurpose. To evaluate the clinical and diagnostic characteristics of patients with newly diagnosed diabetic macular edema (DME) in Turkey in a real-life setting. Methods. A total of 945 consecutive patients (mean (SD) age: 61.3 (9.9) years, 55.2% male) with newly diagnosed DME were included. Data on patient demographics, comorbidities, ocular history, ophthalmic examination findings including type of DME, central macular thickness (CMT) via time domain (TD) and spectral domain (SD) optical coherence tomography (OCT), and planned treatments were recorded. Results. OCT (98.8%) and fundoscopy (92.9%) were the two most common diagnostic methods. Diffuse and focal DMEs were detected in 39.2% and 36.9% of cases, respectively. Laser photocoagulation (32.1%) and antivascular endothelial growth factors (anti-VEGF; 31.8%) were the most commonly planned treatments. The median CMT in the right eye was significantly greater in untreated than in treated patients [376.5 μm (range: 160–840) versus 342 μm (range: 146–999) (p=0.002)] and in the left eye [370 μm (range: 201–780) versus 329 μm (range: 148–999) (p<0.001)]. Conclusions. This study is the first large-scale real-life registry of DME patients in Turkey. SD-OCT and fundoscopy were the most common diagnostic methods. Laser photocoagulation and anti-VEGF therapy were the most common treatments.http://dx.doi.org/10.1155/2017/3596817 |
spellingShingle | Bora Eldem Sengul Ozdek Ali Osman Saatci Emin Ozmert Esat Ulay Gulsah Nomak Clinical Characteristics of Patients with Newly Diagnosed Diabetic Macular Edema in Turkey: A Real-Life Registry Study—TURK-DEM Journal of Ophthalmology |
title | Clinical Characteristics of Patients with Newly Diagnosed Diabetic Macular Edema in Turkey: A Real-Life Registry Study—TURK-DEM |
title_full | Clinical Characteristics of Patients with Newly Diagnosed Diabetic Macular Edema in Turkey: A Real-Life Registry Study—TURK-DEM |
title_fullStr | Clinical Characteristics of Patients with Newly Diagnosed Diabetic Macular Edema in Turkey: A Real-Life Registry Study—TURK-DEM |
title_full_unstemmed | Clinical Characteristics of Patients with Newly Diagnosed Diabetic Macular Edema in Turkey: A Real-Life Registry Study—TURK-DEM |
title_short | Clinical Characteristics of Patients with Newly Diagnosed Diabetic Macular Edema in Turkey: A Real-Life Registry Study—TURK-DEM |
title_sort | clinical characteristics of patients with newly diagnosed diabetic macular edema in turkey a real life registry study turk dem |
url | http://dx.doi.org/10.1155/2017/3596817 |
work_keys_str_mv | AT boraeldem clinicalcharacteristicsofpatientswithnewlydiagnoseddiabeticmacularedemainturkeyarealliferegistrystudyturkdem AT sengulozdek clinicalcharacteristicsofpatientswithnewlydiagnoseddiabeticmacularedemainturkeyarealliferegistrystudyturkdem AT aliosmansaatci clinicalcharacteristicsofpatientswithnewlydiagnoseddiabeticmacularedemainturkeyarealliferegistrystudyturkdem AT eminozmert clinicalcharacteristicsofpatientswithnewlydiagnoseddiabeticmacularedemainturkeyarealliferegistrystudyturkdem AT esatulay clinicalcharacteristicsofpatientswithnewlydiagnoseddiabeticmacularedemainturkeyarealliferegistrystudyturkdem AT gulsahnomak clinicalcharacteristicsofpatientswithnewlydiagnoseddiabeticmacularedemainturkeyarealliferegistrystudyturkdem |